- Home
- RDCM vs ENTA Comparison
RDCM vs ENTA Comparison
Compare RDCM & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDCM
- ENTA
- Stock Information
- Founded
- RDCM 1985
- ENTA 1995
- Country
- RDCM Israel
- ENTA United States
- Employees
- RDCM N/A
- ENTA N/A
- Industry
- RDCM Computer peripheral equipment
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- RDCM Technology
- ENTA Health Care
- Exchange
- RDCM Nasdaq
- ENTA Nasdaq
- Market Cap
- RDCM 157.9M
- ENTA 127.8M
- IPO Year
- RDCM 1997
- ENTA 2013
- Fundamental
- Price
- RDCM $12.02
- ENTA $5.85
- Analyst Decision
- RDCM Strong Buy
- ENTA Buy
- Analyst Count
- RDCM 1
- ENTA 4
- Target Price
- RDCM $14.00
- ENTA $19.50
- AVG Volume (30 Days)
- RDCM 65.6K
- ENTA 464.3K
- Earning Date
- RDCM 01-29-2025
- ENTA 02-05-2025
- Dividend Yield
- RDCM N/A
- ENTA N/A
- EPS Growth
- RDCM 660.55
- ENTA N/A
- EPS
- RDCM 0.46
- ENTA N/A
- Revenue
- RDCM $58,755,000.00
- ENTA $67,635,000.00
- Revenue This Year
- RDCM $18.92
- ENTA $11.80
- Revenue Next Year
- RDCM $11.27
- ENTA $3.99
- P/E Ratio
- RDCM $25.43
- ENTA N/A
- Revenue Growth
- RDCM 17.80
- ENTA N/A
- 52 Week Low
- RDCM $7.70
- ENTA $5.84
- 52 Week High
- RDCM $12.84
- ENTA $17.80
- Technical
- Relative Strength Index (RSI)
- RDCM 55.45
- ENTA 24.81
- Support Level
- RDCM $11.50
- ENTA $5.84
- Resistance Level
- RDCM $12.80
- ENTA $6.56
- Average True Range (ATR)
- RDCM 0.52
- ENTA 0.73
- MACD
- RDCM -0.06
- ENTA -0.18
- Stochastic Oscillator
- RDCM 47.35
- ENTA 2.67
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.